Xuefu Zhuyu Oral Liquid Trial: Effects on Stable Angina Pain Intensity

A multicenter randomized controlled trial conducted across six hospitals in China between June 2020 and June 2022. The study evaluated the efficacy and safety of Xuefu Zhuyu oral liquid as adjunctive therapy for 148 patients with stable angina. Results were published by author Wencong Cao.

Use Cases

• Analyzing the efficacy of adjunctive traditional Chinese medicine based on pain intensity scores.
• Comparing rescue medication usage rates between treatment and placebo groups.
• Evaluating the safety profile of a herbal intervention based on adverse event reporting.
• Modeling longitudinal treatment effects based on 12-week and 24-week follow-up data.

Strengths

• The trial was a multicenter, randomized, double-blind, placebo-controlled design, a rigorous methodology.
• Results include specific statistical outcomes, such as an adjusted mean difference of -0.63 for pain scores.
• The dataset is associated with a registered clinical trial (ChiCTR1900026899), providing provenance.

Limitations

• The dataset is a 10.8 KB DOCX file, likely containing summary text rather than raw patient-level data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, author Wencong Cao.

Collection Method

Data collected from a clinical trial.

Time Range

June 2020 to June 2022.

Freshness

Last updated 2026-04-29 05:54:24; freshness should be verified.

Geography

Six hospitals in China.